Remember last year around this time? We were all saying “good riddance” to a crummy 2016, and the biggest worry on our minds was that uncle Eric would show up in a MAGA hat that would clash with aunt Patty’s women’s march pussy toque, and there’d be a knock-down-drag-out over the dinner table.
This year, we can all unite over our political differences and let the mutual disgust-slash-amusement over Trump’s Twitter feed bind us closer together than ever. Unless, of course, someone brings up marijuana (of course someone will)
So, what is one to do when faced with the dilemma of either speaking up like a proud advocate or cowering, blush-faced, behind the centerpiece until the conversation changes direction? The choice is yours and should take into consideration set and setting. But, if you do intend to engage the conversation, you might want to arm yourself with some quick talking points before you go. That uncle Eric is easily riled up after his second glass of wine.
Talking Point 1: There is such a thing as medical marijuana, and it’s not about getting high.
Many cannabis patients rely on products that contain CBD and little to no THC—like CBD oils to treat children with seizures. CBD has significant therapeutic benefits in all kinds of cases where non-psychoactive cannabis products are preferred.
Some people (non-patients) take it daily to improve their overall health, believing that it helps replace other items in their medicine cabinets, such as anti-inflammatories and immunity boosters.
Hot tip for the table: Tell the fam to pick up a CBD oil tincture once it’s legalized and see for themselves. MedReleaf and Canna Farms both make high-quality products.
Talking Point 2: It continues to be a promising investment opportunity.
Forget the gold rush, we’re in the green rush, baby. Veteran investors and first-timers are wetting their beaks in an industry they probably never thought they’d be able to make money from, legally. It’s trendy and speculative, but at least they’re trading in real money—not cryptocurrency. Just another way to get involved in cannabis without getting high.
Hot tip for the table: Canopy Growth, Aphria, MedReleaf and GW Pharmaceuticals have performed very well this year.
Talking Point 3: Legalized marijuana offers a substitution for people who use opioids.
The opioid overdose epidemic is Canada’s gravest public health crisis since the ’80s, and although Fentanyl is the latest buzzword attached to the problem, it’s hardly the entire picture. Many Canadians are dependant on various forms of opiate drugs—more than 20 million opioid prescriptions are filled each year in Canada. The point is that it reached across demographic divides and none of it is healthy. Almost one in five Canadians live with some form of chronic pain, and prescription opioids are involved in nearly half of the drug-related deaths in North America. In a benchmark 2014 study, researchers found that states that had legalized medical cannabis saw 25 percent fewer opioid-related deaths over ten years compared to states where medical cannabis remained illegal.
Alana seeks to see cannabis from the perspective of politicians, advocates, entrepreneurs, and consumers. She got her start with a byline in the arts and culture section and crossed over into cannabis after using it medicinally. Current projects include investigations into cannabis and wellness; entrepreneurs of the Green Rush; cannabis for athletes; and the evolution of cannabis laws and culture in Canada.